Lippis Daniel J.
CVP, TAVR
In the last 12 months, Lippis Daniel J. filed 49 SEC Form 4 transactions across 1 issuer: $0 in open-market purchases and $871.6K in open-market sales. 31% of these transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.
- $0Open-market buys (1y)
- $871.6KOpen-market sells (1y)
- 49Transactions filed
- 1Distinct issuers
- 31%Under Rule 10b5-1
- 2026-09-11Latest filing
Issuers Filed For By open-market buy volume
Recent Form 4 Filings Most recent 49 of 49 (1-year window)
| Date | Ticker | Company | Type | SEC Code | Value | Shares | Price |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | EW | Edwards Lifesciences Corp | Exercise 10b5-1 | M | $45.0K | 619 | $72.7 |
| 2026-09-11 | EW | Edwards Lifesciences Corp | Exercise | M | $0 | 619 | $0.0 |
| 2026-09-11 | EW | Edwards Lifesciences Corp | Sell 10b5-1 | S | $54.2K | 619 | $87.5 |
| 2026-08-11 | EW | Edwards Lifesciences Corp | Exercise 10b5-1 | M | $45.0K | 619 | $72.7 |
| 2026-08-11 | EW | Edwards Lifesciences Corp | Exercise | M | $0 | 619 | $0.0 |
| 2026-08-11 | EW | Edwards Lifesciences Corp | Sell 10b5-1 | S | $57.0K | 619 | $92.0 |
| 2026-07-10 | EW | Edwards Lifesciences Corp | Exercise 10b5-1 | M | $45.0K | 619 | $72.7 |
| 2026-07-10 | EW | Edwards Lifesciences Corp | Exercise | M | $0 | 619 | $0.0 |
| 2026-07-10 | EW | Edwards Lifesciences Corp | Sell 10b5-1 | S | $56.8K | 619 | $91.7 |
| 2026-07-07 | EW | Edwards Lifesciences Corp | Other | F | $35.9K | 377 | $95.2 |
| 2026-06-30 | EW | Edwards Lifesciences Corp | Exercise 10b5-1 | M | $45.0K | 619 | $72.7 |
| 2026-06-30 | EW | Edwards Lifesciences Corp | Exercise | M | $0 | 619 | $0.0 |
| 2026-06-30 | EW | Edwards Lifesciences Corp | Sell 10b5-1 | S | $56.6K | 619 | $91.4 |
| 2026-05-18 | EW | Edwards Lifesciences Corp | Exercise 10b5-1 | M | $45.1K | 620 | $72.7 |
| 2026-05-18 | EW | Edwards Lifesciences Corp | Exercise | M | $0 | 620 | $0.0 |
| 2026-05-18 | EW | Edwards Lifesciences Corp | Sell 10b5-1 | S | $50.3K | 620 | $81.1 |
| 2026-05-11 | EW | Edwards Lifesciences Corp | Other | F | $28.9K | 362 | $80.0 |
| 2026-05-08 | EW | Edwards Lifesciences Corp | Other | F | $37.2K | 450 | $82.8 |
| 2026-05-07 | EW | Edwards Lifesciences Corp | Grant | A | $0 | 7,850 | $0.0 |
| 2026-05-07 | EW | Edwards Lifesciences Corp | Grant | A | $0 | 39,900 | $0.0 |
| 2026-05-07 | EW | Edwards Lifesciences Corp | Grant | A | $0 | 7,850 | $0.0 |
| 2026-05-07 | EW | Edwards Lifesciences Corp | Other | F | $25.7K | 309 | $83.2 |
| 2026-05-04 | EW | Edwards Lifesciences Corp | Exercise | M | $60.4K | 1,019 | $59.3 |
| 2026-05-04 | EW | Edwards Lifesciences Corp | Exercise | M | $0 | 1,019 | $0.0 |
| 2026-05-04 | EW | Edwards Lifesciences Corp | Sell | S | $85.6K | 1,019 | $84.0 |
| 2026-05-03 | EW | Edwards Lifesciences Corp | Other | F | $21.2K | 252 | $84.0 |
| 2026-05-01 | EW | Edwards Lifesciences Corp | Exercise 10b5-1 | M | $60.4K | 1,019 | $59.3 |
| 2026-05-01 | EW | Edwards Lifesciences Corp | Exercise | M | $0 | 1,019 | $0.0 |
| 2026-05-01 | EW | Edwards Lifesciences Corp | Sell 10b5-1 | S | $1.6K | 19 | $84.0 |
| 2026-05-01 | EW | Edwards Lifesciences Corp | Sell 10b5-1 | S | $83.0K | 1,000 | $83.0 |
| 2026-04-06 | EW | Edwards Lifesciences Corp | Exercise 10b5-1 | M | $60.4K | 1,019 | $59.3 |
| 2026-04-06 | EW | Edwards Lifesciences Corp | Exercise | M | $0 | 1,019 | $0.0 |
| 2026-04-06 | EW | Edwards Lifesciences Corp | Sell 10b5-1 | S | $82.5K | 1,019 | $81.0 |
| 2026-03-11 | EW | Edwards Lifesciences Corp | Grant | – | $60.4K | 1,019 | $59.3 |
| 2026-03-11 | EW | Edwards Lifesciences Corp | Grant | – | $0 | 1,019 | $0.0 |
| 2026-03-11 | EW | Edwards Lifesciences Corp | Sell | – | $87.0K | 1,019 | $85.4 |
| 2026-02-22 | EW | Edwards Lifesciences Corp | Grant | – | $34.5K | 432 | $79.8 |
| 2026-02-17 | EW | Edwards Lifesciences Corp | Grant | – | $15.0K | 198 | $75.9 |
| 2026-02-16 | EW | Edwards Lifesciences Corp | Grant | – | $19.6K | 258 | $75.9 |
| 2026-02-12 | EW | Edwards Lifesciences Corp | Grant | – | $0 | 12,820 | $0.0 |
| 2026-01-09 | EW | Edwards Lifesciences Corp | Grant | – | $60.4K | 1,019 | $59.3 |
| 2026-01-09 | EW | Edwards Lifesciences Corp | Grant | – | $0 | 1,019 | $0.0 |
| 2026-01-09 | EW | Edwards Lifesciences Corp | Sell | – | $87.3K | 1,019 | $85.7 |
| 2025-12-12 | EW | Edwards Lifesciences Corp | Grant | – | $60.4K | 1,019 | $59.3 |
| 2025-12-12 | EW | Edwards Lifesciences Corp | Grant | – | $0 | 1,019 | $0.0 |
| 2025-12-12 | EW | Edwards Lifesciences Corp | Sell | – | $85.6K | 1,019 | $84.0 |
| 2025-11-10 | EW | Edwards Lifesciences Corp | Grant | – | $60.4K | 1,020 | $59.3 |
| 2025-11-10 | EW | Edwards Lifesciences Corp | Grant | – | $0 | 1,020 | $0.0 |
| 2025-11-10 | EW | Edwards Lifesciences Corp | Sell | – | $84.2K | 1,020 | $82.5 |
Methodology & FAQ
How These Filings Are Sourced
All transactions on this page are sourced directly from SEC EDGAR. A complete description of the open-market vs grant distinction, the Rule 10b5-1 plan-reference heuristic, and the per-insider name matching is documented in the Methodology.
What companies does Lippis Daniel J. file Form 4 disclosures for?
Lippis Daniel J. has filed SEC Form 4 transactions for 1 issuer in the last 12 months: Edwards Lifesciences Corp (EW).
What does the 10b5-1 badge mean on these transactions?
Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Of Lippis Daniel J.'s 49 reported transactions in the last 12 months, 15 (31%) reference a 10b5-1 trading plan in the Form 4 footnotes.
Are these all the transactions Lippis Daniel J. has executed?
This page shows SEC Form 4 transactions on record in Pactolio's tracked universe for the last 12 months. Form 4 only covers transactions in registered classes of equity at issuers where the person qualifies as an insider (officer, director, or 10% beneficial owner). Trades in funds, foreign issuers, or non-insider positions are not disclosed under Form 4 and are not included here.